This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Gwangju Institute of Science and Technology. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Innovations in Cell Reprogramming by Shin Ae Seo
Introduction
Shin Ae Seo is a prominent inventor based in Damyang-gun, South Korea. He has made significant contributions to the field of cell reprogramming through his innovative research and development. His work focuses on creating compositions that enhance the efficiency of cell reprogramming while minimizing cytotoxicity.
Latest Patents
Shin Ae Seo holds a patent for a composition aimed at inducing cell reprogramming. The patent describes an indazole derivative compound that demonstrates an improved biological profile compared to conventional compounds. This innovative composition is expected to have a substantial impact on the market for cell therapy products due to its non-cytotoxic nature.
Career Highlights
Seo is affiliated with the Gwangju Institute of Science and Technology, where he conducts his research. His work has garnered attention for its potential applications in regenerative medicine and cell therapy. The unique properties of his indazole derivative compound set it apart from traditional compounds used in cell reprogramming.
Collaborations
Shin Ae Seo collaborates with notable colleagues, including Yong Chul Kim and Darren R Williams. Their combined expertise contributes to the advancement of research in cell reprogramming and related fields.
Conclusion
Shin Ae Seo's innovative work in cell reprogramming showcases the potential for new therapeutic approaches in medicine. His contributions are paving the way for future advancements in cell therapy products.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile